Aurobindo Pharma Limited — Updates, 17-03-2026: General Updates
17-03-2026 | 04:26 pm
17-03-2026 | 04:26 pm
Aurobindo Pharma's subsidiary Eugia Pharma's Unit-II received an 'Official Action Indicated' (OAI) classification from the US FDA after an inspection with 09 observations. The company does not foresee any impact on business from this development.
No comments yet. Be the first to comment!
